Mirae Asset Global Etfs Holdings Ltd. Phathom Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,334 shares of PHAT stock, worth $282,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,334
Previous 23,163
0.74%
Holding current value
$282,341
Previous $145,000
53.79%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PHAT
# of Institutions
138Shares Held
60.5MCall Options Held
1.35MPut Options Held
1.19M-
Frazier Life Sciences Management, L.P. Menlo Park, CA12.5MShares$151 Million6.31% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$90.3 Million20.28% of portfolio
-
Invesco Ltd. Atlanta, GA4.14MShares$50.1 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$42.3 Million41.56% of portfolio
-
Black Rock Inc. New York, NY2.93MShares$35.4 Million0.0% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $474M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...